Search Result "macrophages checkpoint inhibitors."
Immune Checkpoint Inhibitors: Basics and Challenges
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 17 Year: 2019 Page: 3009-3025
Author(s): Bin Li,Ho Lam Chan,Pingping Chen
Immune Checkpoint Inhibitors: Recent Clinical Advances and FutureProspects
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 28 Year: 2023 Page: 3215-3237
Author(s): Abid H. Banday
The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy
Journal: Current Drug Targets
Volume: 22 Issue: 9 Year: 2021 Page: 1021-1033
Author(s): Michele Ghidini,Nicola Fusco,Massimiliano Salati,Shelize Khakoo,Gianluca Tomasello,Fausto Petrelli,Dario Trapani,Angelica Petrillo
Clinical Combinatorial Treatments Based on Cancer Vaccines: Combinationwith Checkpoint Inhibitors and Beyond
Journal: Current Drug Targets
Volume: 23 Issue: 11 Year: 2022 Page: 1072-1084
Author(s): Lyudmila V. Savvateeva,Andrey A. Zamyatnin
Immune Checkpoint Inhibitors in AML-A New Frontier
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 545-557
Author(s): Rohit Thummalapalli,Hanna A. Knaus,Ivana Gojo,Joshua F. Zeidner
Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway
Journal: Current Cancer Therapy Reviews
Volume: 13 Issue: 2 Year: 2017 Page: 120-128
Author(s): Yijun Huang,Hong Zhang
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): TheRole of Checkpoint Inhibitors
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 8 Year: 2022 Page: 629-638
Author(s):
Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 28 Year: 2019 Page: 5244-5261
Author(s): Eva Leufven,Ãystein Bruserud
Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 6 Year: 2015 Page: 452-462
Author(s): SaÑd C. Azoury,David M. Straughan,Vivek Shukla
Cancer Immune Evasion in Gastrointestinal Cancer: Can this be Overcome by Combination of Histone Deacetylase and Immune Checkpoint Inhibitors?
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Yuequan Shi,Onyinyechi Duru,Zifang Zou,David Kerr
Doi: 10.2174/9789811405150119050005